Updates on Management of Hereditary Breast Cancer: New Data on PARP Inhibitors Change Recommendations Regarding the Multidisciplinary Care of Breast Cancer Patients with BRCA Mutations

被引：2
|
作者：
McGuire, Kandace P. [1 ]
Arthur, Douglas W. [1 ]
Mamounas, Eleftherios P. [2 ]
机构：
[1] VCU Massey Canc Ctr, Richmond, VA 23298 USA
[2] Orlando Hlth Canc Inst, Orlando, FL USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2022年 / 29卷 / 11期
关键词：
OLAPARIB; CHEMOTHERAPY; SURVIVAL;
D O I：
10.1245/s10434-022-12048-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6504 / 6507
页数：4
相关论文
共 50 条
  • [21] BRCA mutations in the management of breast cancer: the state of the art
    Steven A. Narod
    Nature Reviews Clinical Oncology, 2010, 7 : 702 - 707
  • [22] BRCA mutations in the management of breast cancer: the state of the art
    Narod, Steven A.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (12) : 702 - 707
  • [23] Pathology of hereditary breast cancer in patients with BRCA1, BRCA2 & BRCAX mutations
    Lakhani, SR
    Jacquemier, J
    Sloane, JP
    Gusterson, BA
    Anderson, TJ
    van de Vijver, MJ
    Farid, LM
    Venter, D
    Easton, DF
    Stratton, MR
    LABORATORY INVESTIGATION, 1999, 79 (01) : 25A - 25A
  • [24] Non-BRCA hereditary gene mutations in the Mongol breast cancer patients of Russia
    Gervas, P.
    Denisov, E.
    Kiselev, A.
    Molokov, A.
    Ivanova, A.
    Choynzonov, E.
    Cherdyntseva, N.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S78 - S78
  • [25] Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients
    Verhoog, LC
    Berns, EMJJ
    Brekelmans, CTM
    Seynaeve, C
    Meijers-Heijboer, EJ
    Klijn, JGM
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 119S - 124S
  • [26] BRCA1 germline mutations in Chinese patients with hereditary breast and ovarian cancer
    Li, N
    Zhang, X
    Cai, Y
    Xu, X
    Zhang, L
    Pan, KF
    Wu, LY
    Wang, MR
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 : 172 - 178
  • [27] PARP inhibitors in hereditary breast and ovarian cancer and other cancers: A review
    Mehta, Prashant
    Bothra, Sneha J.
    ADVANCES IN GENETICS, VOL 108, 2021, 108 : 35 - 80
  • [28] Management of the contralateral breast in patients with hereditary breast cancer
    Eccles, DM
    Evans, DG
    BREAST, 2000, 9 (06): : 301 - 305
  • [29] PARP-1 Expression and BRCA1 Mutations in Breast Cancer Patients' CTCs
    Sklias, Thodoris
    Vardas, Vasileios
    Pantazaka, Evangelia
    Christopoulou, Athina
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    Vasilopoulos, Yiannis
    Kallergi, Galatea
    CANCERS, 2022, 14 (07)
  • [30] BRCA2 mutations in hereditary breast and ovarian cancer in France
    SerovaSinilnikova, OM
    Boutrand, L
    StoppaLyonnet, D
    BressacdePaillerets, B
    Dubois, V
    Lasset, C
    Janin, N
    Bignon, YJ
    Longy, M
    Maugard, C
    Lidereau, R
    Leroux, D
    Frebourg, T
    Mazoyer, S
    Lenoir, GM
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (05) : 1236 - 1239
12345